Mimedx Group Inc is a biotech company focused on the development and commercialization of regenerative medicine products, particularly those that utilize allogeneic placental tissues

The company aims to provide advanced solutions for wound care, surgical applications, and orthopedic treatments through its innovative therapies that promote healing and tissue regeneration. Mimedx's products are designed to support patient recovery by harnessing the natural properties of human placental tissues, thereby enhancing the body’s own healing processes. By combining scientific expertise with cutting-edge technology, Mimedx is committed to improving patient outcomes in various medical fields.